Identification of myogenic cell targeting ligands is a critical observed in regenerating fibers of patients with Duchenne step in the development of synthetic vectors for gene delivmuscular dystrophy and the ability to direct a large enzyme ery to skeletal muscle. Here we describe the screening of conjugate to the cytoplasm of myotubes. Finally, we show six potential targeting ligands (insulin, insulin-like growth that incorporation of transferrin into an artificial virus confactor I, iron transferrin, gallium transferrin, alpha-bungarosisting of poly-L-lysine-condensed DNA coated with a lipid toxin and carnitine) for their ability to bind dystrophinshell (LPDII formulation) results in ligand-directed delivery deficient myotubes in vitro. Those ligands showing high of DNA to myogenic cells. This is the first report of gene levels of binding to myotubes were then tested on fully diftransfer to myogenic cells using a ligand-directed synthetic ferentiated, isolated, viable myofibers. Of the ligands vector. These results suggest that rational design of ligandtested, transferrin showed the most promise based on high directed, fully synthetic, gene delivery vehicles is a viable levels of binding to myogenic cells, high levels of receptor approach to skeletal muscle vector development.
Introduction
ing the use of nontargeted cationic liposomes 8 or cationic The development of highly efficient methods for wideliposomes combined with polylysine condensed DNA 9 to spread, systemic delivery of genes to skeletal muscle will direct gene delivery to myoblasts and myotubes in culbe critical to the success of gene-based therapies for pri-
ture. These studies demonstrate that myoblasts are mary genetic muscular disorders. For example, phenoefficiently transfected using cationic liposomes, and that typic correction of Duchenne muscular dystrophy is estiprecondensation of DNA with poly-lysine enhances lipomated to require restoration of about 20% of normal fection. However, the overwhelming charge interaction dystrophin levels in affected muscles. 1, 2 No currently between positively charged liposome-DNA complexes available vector can acheive this efficiency of gene transand negatively charged cell membranes and extracellular fer in a tissue that represents 30% of a patient's body matrix makes specific targeting difficult. A possible solmass. Traditional approaches for gene delivery to skeletal ution to this problem is the use of a newly developed muscle have focused on the intramuscular injection of liposomal vector, LPDII, which can be manipulated to be viral vectors (adenovirus (ADV), retrovirus (RV), herpes neutral or anionic in overall charge and thus able to intervirus type 1 (HSV-1) ). An alternative avenue, largely act with cells in a ligand-dependent manner. 10 Such vecunexplored for skeletal muscle, is to develop rationally tors are similar in size to viral vectors with an average designed, fully synthetic gene delivery vectors for sysdiameter of 100-150 nm, and have been shown to temic delivery. Such vectors could be designed to be of mediate transient transduction of several cell types (L low immunogenicity/toxicity, targeted to skeletal Huang, personnal communication). We hypothesized muscle, stable in the bloodstream, produced easily on a that charge-neutral, entrapped DNA liposomes could be large scale and capable of mediating transduction with developed which would show transduction of myogenic high efficiency. cells in a ligand-dependent manner.
Most efforts to develop targeted synthetic vectors have
Here we describe the rational design of a synthetic vectaken advantage of receptor-mediated endocytosis 3,4 to tor for ligand-directed gene delivery to myogenic cells. direct gene delivery to nonmyogenic cells. For example, First, candidate muscle binding ligands were screened to the use of synthetic vectors to deliver genes to hepatoquantify their levels of association with myotubes genercytes has yielded promising results both in vitro 5 and in ated from a conditionally immortalized, nontumorigenic, dystrophin-deficient myogenic murine cell line. 11 Second, ligands identified as having high levels of association with myotubes were screened for their ability to bind iso-muscular dystrophy patients. Third, selected ligands otoxin 15 (2.31 ± 0.656 pmoles/mg cell protein). Carnitine 16 (0.831 ± 0.156 pmoles/mg cell protein) and IGF-1 17, 18 were tested for their ability to direct a large macromolecule (avidin/␤-galactosidase) to myogenic cells in vitro.
(0.147 ± 0.056 pmoles/mg cell protein) showed an intermediate level of association. Specific binding of insulin 19 Finally, one of the identified ligands was tested for its ability to direct transfection of myogenic cells by LPDII. was below the level of detection. Based on these results, iron transferrin and bungarotoxin were selected for additional testing.
Results
Transferrin but not bungarotoxin shows maturationTransferrin and alpha-bungarotoxin show high levels of dependent decline in total association with myogenic myotube association cells We applied three criteria to select a subgroup of known Myotubes represent a very early stage in the differenmuscle-binding ligands for biochemical screening. First, tiation of myogenic cells, therefore it is important to the preferred molecular weight of the ligand was less examine the levels of ligand binding to fully differenthan 100 kDa, based on the rationale that the ligand tiated myogenic cells. This was accomplished by studyshould not contribute greatly to the size of the gene deliving the binding of bungarotoxin and iron transferrin to ery vehicle into which it was eventually to be incorporfreshly dissociated, viable, myofibers isolated from mice ated. Second, ligands were chosen that show binding to (Figure 2a and b) . These fibers display characteristics of mature skeletal muscle through a cell surface receptor highly differentiated muscle, including complete basal with relatively high affinity (sub-micromolar K d ). Finally, laminae, well-organized neuromuscular junctions, and the ligands selected were amenable to chemical modifimyotendinous junctions. [20] [21] [22] cations allowing radiolabeling or attachment to macroLigand association with extensor digitorum longus molecules for delivery to myogenic cells. Based on these (EDL) myofibers isolated from 2-month-old mdx mice criteria six ligands were chosen for screening.
under conditions identical to those used for ligand bindDystrophin gene and protein replacement in vivo is a ing to myotubes (200 nm, 1.5 h, 37°C) revealed much long-term goal of these studies. Because dystrophin lower levels of transferrin than alpha-bungarotoxin deficiency may have unknown effects on receptor levels in myotubes and myofibers, dystrophin-deficient myotubes seemed the most appropriate cell with which to screen for ligand binding. 11 Binding studies of radiolabeled ligands at a fixed concentration (200 nm) with dystrophin-deficient myotubes ( Figure 1) (Figure 3a) . The level of alpha-bungarotoxin association was comparable to that measured in myotubes, while the level of transferrin association was approximately 60-fold lower than that with myotubes. Transferrin association with mdx myoblasts was also lower than the association with myotubes (0.843 ± 0.126 pmoles/mg cell protein, data not shown). Transferrin association with normal mouse (C57BL/6J or C57BL/10J) skeletal muscle was determined using single fibers isolated from hind-limb anterior compartment (5-day, 1-month, and 2-month mice) (Figure 3b ) and posterior compartment (5-day-old, 2-week-old and 1-month mice) (Figure 3c ) muscles. Transferrin association decreased by three-fold for both anterior and posterior compartment muscles between day-5 and 1-month-old animals. These observations suggest that transferrin association per milligram of cell protein peaks in myotubes, then declines with fiber maturation. The abrupt decline in transferrin association between myotubes and single fibers is probably exaggerated by an increase in contaminating nonfiber protein in the single fiber binding assay. However, the maintenance of high levels of alpha-bungarotoxin association with single fibers suggests that this error is probably not large.
Transferrin receptor is present in elevated levels in regenerating fibers in patients with Duchenne muscular dystrophy Based on the above observation that transferrin association is greatest with intermediately differentiated murine myogenic cells, we hypothesized that elevated levels of transferrin receptor should be present on regenerating human myofibers. To test this hypothesis, immunofluorescence was used to examine transferrin receptor levels in frozen sections of muscle biopsies from normal and Duchenne muscular dystrophy patients (in which regenerating fibers are a prominent histological feature 23 ). Transferrin receptor staining in normal individuals was faint, punctate and almost entirely associated with the sarcolemma (Figure 4a ). In Duchenne patients, however, regenerating fibers (small, eosinophilic and centrally nucleated by hematoxylin and eosin staining) showed intense cytoplasmic as well as sarcolemmal staining (Figure 4b ). In contrast, transferrin receptor staining in fully mature fibers was not different from that observed in the normal biopsy. Sections to which no primary antibody was added showed no staining (data not shown). These observations suggest transferrin receptor levels are highly elevated in regenerating myofibers in humans. with estimated disassociation constants of less than 100 nm. Furthermore, addition of streptavidin modified activity was not limited to the endosomal or lysosomal compartment.
Similar experiments were carried out using biotin-bungarotoxin as the targeting ligand. Despite the observed association of radiolabeled bungarotoxin and biotinylated bungarotoxin with myotubes, no ligand-specific association of ABG with myotubes was observed (data not shown). This suggests that complexing ABG to biotin-alpha-bungarotoxin may result in steric hindrance, blocking the ability of bungarotoxin to bind the acetylcholine receptor on the surface of myotubes. Alternatively, biotin-bungarotoxin may not associate with avidin-␤-galactosidase in an orientation that permits binding of bungarotoxin to the acetylcholine receptor.
To quantify biotin-transferrin-driven association of ABG with myotubes and myoblasts and to determine the extent of endocytosis of the complex, cells were incubated at 37°C and 0°C in the presence of targeted ABG or ABG plus free transferrin. Quantitative assay of biotintransferrin-directed association of ␤-galactosidase activity showed myoblasts and myotubes bind essentially equal amounts of the enzyme conjugate at 0°C (22.7 ± 2.8 pmol/mg cell protein, and 23.9 ± 2.0 pmol/mg cell protein, respectively) ( Figure 7 ). However, at 37°C, the amount of enzyme association with myotubes (59.67 ± 5.65 pmol/mg cell protein) was approximately two-fold that observed in myoblasts (35.8 ± 8.4 pmol/mg cell protein). These observations suggest that the bound ligand-enzyme complex is internalized and that the mechanisms of internalization may change with myogenesis. constructed by first condensing plasmid DNA containing a reporter gene using poly-l-lysine followed by interaction of the DNA-polylysine complexes with transferrinthe binding characteristics of both biotinylated ligands (data not shown). These observations suggested biotin modified, DOPE/CHEMS liposomes. These transferrintargeted LPDII particles containing DNA encoding ␤-modified transferrin and alpha-bungarotoxin maintain the ability to bind their respective myotube receptors galactosidase or luciferase reporter genes were then used to transfect both myoblasts and myotubes. Myoblasts with high affinity.
Biotin-transferrin was bound to an enzyme conjugate were transfected 24 h after plating, then switched to differentiation media, and harvested at day 2 and 5 of differ-(avidin-␤-galactosidase (ABG)) and the delivery of enzyme to myogenic cells was tested with and without entiation for measurement of luciferase activity, or fixed with 2% glutaraldehyde and stained for ␤-galactosidase excess unlabeled transferrin. Cytochemical staining of myotubes for ␤-galactosidase activity revealed a low activity (day 5 only), as previously described. Myotubes were transfected at day 5 of differentiation, and assayed level of nonspecific association of ABG with myotubes ( Figure 5a ). Complexing ABG with biotin-transferrin 2 days later. For transfections, cells were incubated for 5 h at 37°C with 2 g of DNA complexed in either greatly enhanced the level of myotubeassociated ␤-galactosidase activity (Figure 5b ). This comuntargeted LPDII, transferrin-LPDII, transferrin-LPDII plus excess free transferrin (11.3 m) or lipofectamine. plex was soluble, as 15-min microcentrifugation of the targeted enzyme complex before addition to the ␤-Galactosidase staining at day 5 of differentiation showed that nontargeted LPDII was extremely inefficient myotubes did not detectably alter association (Figure 5c ). Addition of excess free transferrin greatly reduced the at generating transduced myotubes from transfected myoblasts (Figure 8a ). In contrast, transfection of myoamount of cell-associated enzyme activity (Figure 5d ), demonstrating that the observed uptake of biotin-transblasts using transferrin-targeted LPDII resulted in approximately 5% transduced myotubes (Figure 8b ). This ferrin-avidin-␤-galactosidase is not simply a result of transferrin-stimulated, nonspecific endocytosis. The unilevel of transduction was similar to that observed using the cationic liposome formulation, lipofectamine (data form distribution of staining observed in association with the myotubes (Figure 6 ) suggests that the ␤-galactosidase not shown). We next tested the ability of transferrin- LPDII to transfect fully differentiated (day 5) myotubes. (Figure 8d ). The great decrease in transduction observed with maturation of myoblasts to myotubes suggests that ␤-Galactosidase staining of myotubes showed that transferrin-LPDII resulted in only one or two visibly transthe post-binding fate of transferrin-LPDII differs between these cell types. duced myotubes per well (data not shown).
To examine more quantitatively the transduction of both myoblasts and myotubes, transfection experiments Discussion were carried out using luciferase as the reporter gene. Luciferase assay of lysates of myotubes generated from Our long-term goal is to develop a fully synthetic gene delivery vehicle for systemic gene therapy of muscle in myoblasts transfected with untargeted LPDII, transferrin-LPDII, transferrin-LPDII plus excess transferrin and lipovivo. In this article we describe intermediate steps towards this goal: we describe experimental systems for fectamine confirmed the observations made using the ␤-galactosidase reporter gene (Figure 8c) . Incorporation of screening of potential ligands, identification and testing of candidate ligands, and construction of a fully synthetic transferrin into LPDII yielded a 16-fold enhancement of reporter gene activity over untargeted LPDII, with total targeted liposome which transduces myoblasts at a high efficiency. To select compounds for testing as targeting levels of transfection slightly better than those achieved using the cationic liposome, lipofectamine. Importantly, ligands for skeletal muscle, we considered the amount of functional receptors on target cells, the cell specificity of free transferrin was able to compete away transfection by transferrin-LPDII, while a nonspecific protein (bovine receptors, the ability to modify ligands for coupling to delivery vehicles, and the intracellular fate of ligandserum albumin) had no effect on transduction (data not shown). This suggests that the transduction of myoblasts receptor complexes. Of these, we chose to use the amount of functional receptor as the primary selection criterion, by transferrin-LPDII resulted from transferrin-mediated uptake of the particle rather than from a nonspecific based on the relatively low transduction efficiency of current synthetic vectors in skeletal muscle, the fact that effect of transferrin on cellular endocytic activity. Identical trends in transduction efficiency were observed when muscle represents a very large target organ, and that muscle-specific gene promotors are available.
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myotubes were transfected, although the levels of reporter gene expression were approximately 10-fold less The lack of quantitative ligand association data for
Figure 6 Biotin-transferrin directs avidin-␤-galactosidase to myotube cytoplasm. Shown is a high power image of a multinucleate myotube stained for ␤-galactosidase activity subsequent to incubation for 3 h at 37°C in the presence of avidin-␤-galactosidase coupled to biotin transferrin. The lack of punctate cytoplasmic staining suggests that enzyme activity is not limited to the endosomal or lysosomal compartment in the myotube cytoplasm (scale bar = 40 m).
and 2.31 ± 0.656 pmoles/mg cell protein, respectively).
Ligands showing lower levels of association (gallium transferrin, 1.18 ± 0.263 pmoles/mg cell protein; carnitine, 0.813 ± 0.156 pmoles/mg cell protein; insulin-like growth factor I, 0.147 ± 0.056 pmoles/mg cell protein; insulin, not detectable) were excluded from further development in this study. Future artificial vectors may have higher transduction efficiency which will make receptor quantity less important and hence, ligands with low levels of highly muscle-specific receptors more useful targeting candidates. Our concern that myotubes may not accurately represent the ligand-binding ability of fully mature skeletal muscle in vivo led us to adapt a method for single fiber preparation to ligand association studies. This provided us with an in vitro system in which the levels of ligand association with fully mature, living muscle could be quantified (Figure 3) . Furthermore, we have previously shown that single fibers can be prepared from murine
Figure 7 Biotin-transferrin coupled to avidin-␤-galactosidase is internalized by myotubes and myoblasts. Biotin-transferrin-specific association of models of human genetic diseases (eg dystrophin-

avidin-␤-galactosidase with myoblasts (MB) and myotubes (MT) at 0°C deficient mice (mdx) and merosin-deficient mice and 37°C was measured by ONPG assay (see Materials and methods).
(dy/dy)) and that these can be transduced by viruses.
22,25
Myotubes were incubated in the presence of biotin-transferrin coupled
Thus, single fibers provide a good in vitro model for to avidin-␤-galactosidase or avidin-␤-galactosidase plus unbiotinylated
future studies of skeletal muscle gene delivery via tartransferrin, specific association was defined as the difference in ␤-galactosidase activity between these conditions. Myotubes show a higher degree geted synthetic vectors.
of conjugate uptake (as measured by the difference between association at
Using the single fiber system, we found that the levels
37°C and 0°C) than do myoblasts (n = 3 or greater wells per condition).
of transferrin association with myogenic cells changed as a function of cell maturation. The greatest association was observed in myogenic cells of intermediate differenskeletal muscle in the literature motivated us to screen tiation (cultured myotubes (1.56 ± 0.417 pmoles/mg cell candidate ligands for association with dystrophinprotein)), while low levels of association were seen with deficient myotubes under constant binding conditions. Of fully mature EDL fibers from 2-month-old mice the six ligands screened, iron transferrin and alpha-(0.025 ± 0.014 pmoles/mg cell protein). This represents a bungarotoxin were selected for further testing as tar-60-fold decrease in cell association of transferrin with geting ligands due to their high levels of specific association with myotubes (1.56 ± 0.417 pmoles/mg cell protein maturation. In contrast, bungarotoxin association with EDL fibers from 2-month-old mice (1.43 ± 0.314 fluorescently tagged molecules and found the uptake to be segmental on the myotube and that the endocytosed pmoles/mg cell protein) was well preserved, maintaining about 60% of the association observed in myotubes. Thus, substance was limited to vesicles in the cytoplasm. 26, 27 Our results confirm the previously observed segmental the choice of ligand for receptor-mediated gene delivery may depend on the differentiation state of the target cell nature of HRP uptake by myotubes, 27 and suggest that this phenomenon is associated with both receptorand the specific disease involved. The latter point is underscored by our observation that regenerating mediated as well as nonspecific endocytic processes. Finally, we conclude that transferrin is an appropriate myofibers in human patients with Duchenne dystrophy show high levels of transferrin receptor while fully choice for directing proteins to myogenic cells via receptor-mediated endocytosis. The success with transmature fibers in normal muscle do not (Figure 4) .
We have shown that transferrin can deliver a funcferrin conjugates contrasts with the failure of bungarotoxin conjugates to deliver functional ␤-galactosidase to tional, high molecular weight enzyme conjugate (avidin-␤-galactosidase) to myotubes. Thus, the transferrin recepmyotubes despite the observed high levels of radiolabeled bungarotoxin association. This suggests that biotintor on the surface of myogenic cells is not sterically hindered and can bind transferrin derivatized with high bungarotoxin was unable to associate with the avidin-␤-galactosidase conjugate in an orientation which permitmolecular weight complexes. In addition, internalization of a transferrin-conjugated enzyme does not result in ted it to interact with the acetylcholine receptor.
We have shown that transferrin-LPDII can mediate immediate inactivation of the enzyme. This suggests that the transferrin-targeted enzyme conjugate was internaltransferrin-directed gene delivery to myoblasts as well as myotubes. The level of transduction achieved by ized by the myotube in an active form (Figures 5-7) . Others have examined myotube and skeletal muscle transferrin-LPDII was roughly equivalent to that of the cationic liposome lipofectamine (Figure 8c and d) , but uptake of nontargeted horseradish peroxidase (HRP) or was almost entirely dependent on the covalent incorpordoes not rely on receptor-mediated endocytosis for efficient transduction. 34 It is unclear if the same ation of transferrin as a targeting ligand, as untargeted LPDII showed no transduction of myoblasts by ␤-galactomechanism(s) governing transduction efficiencies in vitro are also responsible for the maturationally dependent sidase staining (Figure 8a ). This result demonstrates the feasibility of developing fully synthetic vectors for recepdecrease in efficiency of viral vector-mediated gene delivery observed in vivo. 22, 35 Future studies will be directed at tor-mediated gene delivery for muscle. Previously we have shown the ability to achieve targeted delivery of identifying and circumventing maturationally occurring impediments to efficient transduction of mature muscle. LPDII to cancer cells using folate, a small (441 Da) enzyme cofactor. This current work extends our previous data by showing that LPDII can be targeted by a large
Materials and methods
(80 000 Da) protein, transferrin. A critical point is that the Preparation of radiolabeled ligands efficiency of transduction of myogenic cells using transRadiolabeled ligands were purchased or prepared using ferrin-LPDII must be enhanced before moving into in vivo Iodogen (Pierce, Rockford, IL, USA) as previously studies. This is illustrated by our observations that by described. 36 Saturation of 125 I human apo-transferrin transfecting myoblasts with transferrin-LPDII under opti-(Sigma, St Louis, MO, USA) with five-to 10-fold molar mal conditions we can generate only about 5% transexcess of iron (Fe+++) or gallium (Ga+++) was confirmed duced myotubes, while with HSV-1 and ADV vectors we spectrophotometrically 37 with parallel studies of unlabcan achieve essentially 100% transduction. Futhermore, eled apotransferrin. It is thought that mammalian transpreliminary in vitro studies on single isolated myofibers ferrins are interchangeable with regard to receptor speciand in vivo studies in newborn animals suggest transficity, 38 therefore human transferrin was used in place of ferrin-LPDII has very low ability to transduce myofibers mouse transferrin in all binding studies. Specific activities (unpublished observations). Enhancement of transducof ligands as tested ranged from 5-81 Ci/mmol. tion efficiency might be accomplished by further enabling transferrin-LPDII to fuse with cells through incorporation Myogenic cell preparation and ligand association studies of fusigenic peptides, 28 by altering the choice of targeting Conditionally immortalized myoblasts derived from ligand, by enhancing the nuclear transport of the particle, male mice hemizygous for mdx and heterozygous for Hor by lessening the dependence on the nuclear transcrip-2K b -tsA58 11 were grown at 34°C in growth media contional apparatus. 29 sisting of DMEM supplemented with 10% horse serum, Our data showed that myotubes were 10-fold less 20% fetal calf serum, 2% l-glutamine, 1% penicillinefficiently transduced than myoblasts by transferrinstreptomycin, 1% chick embryo extract and 20 U/ml of LPDII (Figure 8c I transferrin than myoblasts (1.56 ± 0.417 pmoles/mg (Collaborative Biomedical Products, Bedford, MA, USA) cell protein and 0.843 ± 0.126 pmoles/mg cell, coated plates (0.1 mg/ml) in differentiation media respectively), which is in agreement with the results of (DMEM containing 1.25% horse serum, 1.25% fetal calf others that have shown myoblasts have fewer transferrin serum, 2% l-glutamine, and 1% penicillin-streptomycin) receptors than do myotubes. 30, 31 Second, myotubes and grown at 37°C (non-permissive conditions). showed approximately two-fold greater levels of associMyotubes, some of which displayed spontaneous conation and internalization of transferrin-targeted avidintractions, were used at day 4-6 after switch to differen-␤-galactosidase than did myoblasts (59.67 ± 5.65 tiation media. Myoblasts were used the day after plating pmol/mg cell protein and 35.8 ± 8.4 pmol/mg cell proin growth media without gamma interferon at 37°C (nontein, respectively). It seems likely, therefore, that the difpermissive conditions). Protein determinations were carference in transduction efficiency is the result of a change ried out using the DC protein assay (Bio-Rad, Hercules, in how myotubes handle the transferrin-LPDII particle CA, USA). Protein contributed to cell lysates by the after binding. Interestingly, others have observed a Matrigel coating of plates was below limits of detection similar, promotor-independent decrease in transfection of the assay. efficiency between myoblasts and myotubes with untarAssociation of ligands with dystrophin-deficient geted cationic liposomes 8, 9 and adenoviral vectors. 32, 33 myotubes at 5-7 days of differentiation or myoblasts the Together these observations suggest that there may be a day after plating was determined as follows. Cells were common basis for the decreased transduction efficiency pre-incubated at 37°C for 1.5 h in DMEM containing 2.5% of myotubes by these gene delivery vehicles. Possible bovine serum albumin. Radiolabeled ligands were then mechanisms for such a decrease in transduction added to a final concentration of 200 nm and allowed to efficiency include: decreased endocytosis of large incubate with cells for 1.5 h at 37°C. Nonspecific binding complexes (although our data showing high levels of was measured in the presence of at least 25-fold excess transferrin-directed enzyme conjugate uptake by unlabeled ligand. Cells were rinsed four times with phosmyotubes argues against this); a decreased ability of phate-buffered saline (PBS), lysed in 0.1 m NaOH and endocytosed particles to gain access to the cytoplasm of radioactive incorporation determined using a gamma or myotubes; increased degradation of internalized DNA; liquid scintillation counter. decreased ability of DNA to reach the nuclear transcriptional apparatus; and/or altered handling of exogenous Single fiber association studies Normal (C57BL/10J or C57BL/6J) and mdx (dystrophin-DNA at the level of the nucleus. Importantly, HSV-1 infects myoblasts and myotubes equally well in vitro, and deficient, C57BL/10ScSn mdx) mice were bred in insti-672 tutional animal facilities or obtained from Jackson Labligands in subsaturating concentrations (1.2 nm for transferrin, 1 nm for alpha-bungarotoxin) were incubated with oratory (Bar Harbor, ME, USA). Immediately after the death of the mice, single fibers were prepared from discells for 1.5 h at 0°C in the presence of increasing amounts of biotinylated ligand or biotinylated ligand sected soleus or extensor digitorum longus (EDL) muscle by enzymatic disaggregation in 0.2% type 1 collagenase with constant (at least a four-fold molar excess) of streptavidin. Cells were rinsed three times in PBS, lysed in (Sigma) as described elsewhere. 39 Due to the small size of the animals less than 5 days old, anterior compartment 0.1 m NaOH, and radioactive incorporation determined using a gamma counter. and posterior compartment muscles were removed en bloc from the lower leg for disaggregation. For 2-week or
To determine qualitatively if biotin-modified ligands were capable of directing avidin-␤-galactosidase to cells, older animals, the EDL muscle was removed as a representative anterior compartment muscle, while the myotubes prepared as described above were incubated at 37°C for 3 h in serum-free media containing either soleus muscle was removed from the posterior compartment. Fibers were purified from smaller contaminants avidin-␤-galactosidase (ABG, mw 223 200-322 200 Da depending on lot; Sigma), biotinylated ligand plus ABG (small pieces of connective tissue, free cells) by rinsing the fibers in DMEM, then decanting the DMEM from (combined 15 min before addition to the cells at a 1:1 molar stoichiometry) or biotinylated ligand plus ABG above the fibers immediately after fiber settling. Fiber viability was determined using trypan blue exclusion; in plus a Ͼ25-fold molar excess of free unmodified ligand. Final biotinylated ligand concentrations were Ͼ75 nm. practice there was a near 100% correlation between fiber death and visible hypercontraction.
Cells were rinsed once with DMEM/2.5% BSA and three times with PBS, fixed in 2% glutaraldehyde (Sigma) and Three aliquots of pooled fibers from four to six muscles in a small amount of medium (100-200 l) were incustained for ␤-galactosidase activity. 40 To assess quantitatively the ability of biotin-transferrin bated at 37°C for 1.5 h in the presence of 200 nm radiolabeled ligand; nonspecific binding was measured in at least to direct ABG to myoblasts and myotubes, cells prepared as above were incubated with biotin-transferrin com-25-fold excess unlabeled ligand. After rinsing in DMEM (three times) and PBS (once), fibers were lysed in 0.1 m plexed ABG (combined 15 min before addition to cells at a 1:1 molar ratio of biotin-transferrin to avidin in the NaOH and radioactive incorporation determined using a gamma counter. Protein was determined as for ABG complex, final concentration in biotin-transferrin, 700 nm) or free native transferrin plus ABG similarly premyotubes.
pared. Cells were incubated for 3 h at 0°C or 37°C, rinsed as described above, then collected by brief (3 min) trypImmunofluorescence for transferrin receptor Flash frozen muscle biopsies from two normal (age 4 sinization (1 × trypsin/EDTA (Sigma) ). Rinsed cell pellets were resuspended in 100 l of 0.25 m Tris (pH 7.8) years) and two individuals with Duchenne muscular dystrophy (age 3 years) were processed for transferrin then disrupted by three freeze-thaw cycles followed by 30 s of sonication (model w380; HeatSystems-Ultrasonics, immunofluorescence. Briefly, unfixed, 8 m cryosections were thawed on Superfrost Plus (Fisher, Pittsburgh, PA, Farmingdale, NY, USA). ␤-Galactosidase activities were determined by o-nitrophenyl-␤-d-galactopyranoside USA) slides, and incubated for 2 h at room temperature in phosphate-buffered saline/10% horse serum (PBS/HS) (ONPG) assay, 41 and cell protein was determined as above. Specific association was defined as biotincontaining monoclonal antibody against human transferrin receptor (1:40, MAB clone B3/25 (Boehringertransferrin/ABG association minus transferrin/ABG association. Mannheim, Indianapolis, IN, USA)). For each biopsy, parallel sections without primary antibodies were also processed. After rinsing with PBS, biotinylated sheep Transferrin-lipid-polylysine-DNA (TFLPDII) constructs, lipofection, and reporter gene assays anti-mouse antibody was applied (1:250 (Amersham, Arlington Heights, IL, USA)) for 45 min, followed by pH-sensitive liposomes composed of cholesteryl hemisuccinate (CHEMS)/dioleoylphosphatidylethanolamine rinsing and application of streptavidin-Texas Red (1:250, Gibco-BRL) for 15 min. Exposure times for both film and (DOPE)/iron transferrin-N-glutaryl phosphatidylethanolamine (NGPE) were prepared by detergent dialyprints were held constant for all sections. sis method. Briefly, lipid films composed of DOPE and CHEMS (6:4; mol/mol) were formed under a nitrogen Transferrin-enzyme conjugates Biotin-transferrin was prepared by reacting iron transstream and suspended in 20 mm Hepes/150 mm NaCl, pH 8.0. The lipid suspension was sonicated with a bath ferrin with amino-reactive biotin containing a longchain spacer arm (succinimidyl-6-(biotinamido) hexanosonicator and the pH was adjusted to 8.0. Conjugation of transferrin to NGPE was performed as previously ate (Pierce) ) following the manufacturer's instructions. Free biotin was removed by three rounds of concendescribed. 42 Briefly, NGPE dissolved in CHCl 3 was dried with N 2 gas and vacuum desiccated. The dried NGPE tration and resuspension in a microconcentrator (molecular weight cut-off 30 kDa, Amicon), and the was then solubilized in 0.15 m octyl-glucoside (OG) at a NGPE:OG ratio of 0.06:1 (mol/mol) in 2-(N-morpholino) degree of biotin incorporation was determined by HABA-dye (2-(4′-hydroxyazobenzene) benzoic acid; ethansulfonic acid (MES) buffer (10 mm MES/150 mm NaCl, pH 5.0). 1-Ethyl-3(3-dimethylaminopropyl) carPierce) assay following the manufacturer's instructions. Biotin-alpha-bungarotoxin was obtained commercially bodiimide (EDC) and N-hydroxysulfosucciniimide (Sulfo-NHS) were added to the above mixture to a (Molecular Probes, Eugene, OR, USA). To assess the ability of modified ligands to bind with high affinity to NPE/EDC/Sulfo-NHS ratio of 1:50:20 (mol/mol) and then incubated for 10 min at room temperature. The mixtheir myotube receptors, binding competition assays were performed with both biotin-derivatized ligands on ture was neutralized with 100 mm HEPES buffer and 1 N NaOH to pH 7.5. Transferrin containing a trace amount dystrophin-deficient myotubes. Radiolabeled native
